Search results
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 29 minutes agoThe shot, called Arexvy, is the first vaccine cleared by the FDA to protect that population from...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
AOL· 44 minutes agoThe shot, branded Arexvy, as well as vaccines from rivals Pfizer and Moderna are already approved for people aged 60 and older for the ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 hours agoThe vaccine is based on protein technology, differentiating it from Pfizer's and Moderna's messenger...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 11 hours agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 10 hours agoThe vaccine, dubbed...older adults it can be serious or even deadly. Moderna will rival Pfizer and...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 3 days agoChatterjee and Wharton were speaking during a meeting of the FDA's Vaccines and Related Biological...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 3 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 1 day agoThis approval represents a significant development...vaccine to enter the US market following the...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 5 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...